| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8683085 | Clinical Neurophysiology | 2017 | 38 Pages |
Abstract
Findings are important for developing preclinical disease markers in the context of currently emerging disease-modifying therapies of neurodegenerative disorders.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Luis Velázquez-Pérez, Johannes Tünnerhoff, Roberto RodrÃguez-Labrada, Reidenis Torres-Vega, Yusely Ruiz-Gonzalez, Paolo Belardinelli, Jacqueline Medrano-Montero, Nalia Canales-Ochoa, Yanetza González-Zaldivar, Yaimeé Vazquez-Mojena, Georg Auburger,